In this study, we described the role and molecular mechanism of oHSV in inducing TLS formation in tumours, and identified that oHSV therapy recruits stem‐like TCF1+CD8+ T cells via CXCL10/CXCR3 pathway to propagated TLS formation. This evidence concerns the gene CXCL10 and neoplasm.